Number of Shares and Voting Rights of ADOCIA as of February 28th, 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2025
0mins
Source: Businesswire
Company Overview: Adocia SA is a French biopharmaceutical company focused on developing innovative treatments for diabetes and obesity, with a portfolio of drug candidates based on proprietary technologies and over 25 patent families.
Shareholder Information: As of February 28, 2025, Adocia has 18,084,200 outstanding shares, with a total of 20,218,939 theoretical voting rights and 20,187,490 exercisable voting rights, following the issuance of 120,000 new shares related to a financing line.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
